Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-06-20

Clinical Trial Update: Prophylactic Tributyrin Supplementation in Acute Pancreatitis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating prophylactic tributyrin supplementation for acute pancreatitis and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tributyrin (tributyrin)

Snippet

Sponsor: St. Antonius Hospital | Conditions: Acute Pancreatitis | Phase 2 | Status: RECRUITING